EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Sympathectomy inhibits growth of a murine plasmacytoma tumor






Journal of the Autonomic Nervous System 13(2): 149-160

Sympathectomy inhibits growth of a murine plasmacytoma tumor

The effects of 6-hydroxydopamine (6-OHDA), N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) and anti-nerve growth factor (anti-NGF) on the development and growth of a tumor of non-neuronal origin were studied in mice. Murine LPC-1 plasmacytoma cells were grown either s.c. as solid tumors in the hindleg or i.p. in ascitic form. Growth of s.c. tumors was monitored by caliper measurements of the hindleg at the site of tumor cell inoculation; growth of ascitic tumors was followed by electrophoretic determination in plasma of the tumor associated protein IgG2a.kappa., M component. Adult mice were treated with 6-OHDA or DSP-4 6 h prior to tumor cell implantation; newborn mice were treated with anti-NGF and tumor cells were given 9 wk later. Both chemical- and immunosympathectomy significantly altered the growth pattern of solid and ascitic tumors (P < 0.0001). The effect of sympathectomy on the growth of solid tumors was most pronounced during the early phase of tumor growth. The effect of each drug treatment on tumor growth was not due to direct cytotoxic actions of the agents employed on tumor cells but the result of impairment of sympathetic functions. The sympathetic nervous system may play a role in tumor growth.

Accession: 006555705

PMID: 3926856

DOI: 10.1016/0165-1838(85)90031-1

Download PDF Full Text: Sympathectomy inhibits growth of a murine plasmacytoma tumor



Related references

Coulie, P.G.; Vink, A.; Van Snick, J., 1990: A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo. Current Topics in Microbiology and Immunology 166: 43-46

Le, J.; Reis, L.F.; Vilcek, J., 1988: Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line. The survival and proliferation of the murine plasmacytoma cell line T1165 was previously shown to depend on a plasmacytoma growth factor (PCT-GF) produced by the murine P388D1 macrophage cell line. In the present study we examined several cytokine...

Nordan, R.P.; Mock, B.A.; Neckers, L.M.; Rudikoff, S., 1989: The role of plasmacytoma growth factor in the in vitro responses of murine plasmacytoma cells. Many plasmacytomas arising in BALB/c mice are dependent upon a specific, macrophage-derived plasmacytoma growth factor for survival and proliferation in vitro. Adherent cells taken from the peritoneal oil granuloma in which the early plasmacytomas...

Neckers, L.M.; Nordan, R.P., 1988: Regulation of murine plasmacytoma transferrin receptor expression and G1 traversal by plasmacytoma cell growth factor. Many plasmacytomas arising in BALB/c mice require a specific, macrophage-derived growth factor in order to proliferate in vitro. Since transferrin receptor expression is normally regulated by tissue-specific growth factors and because expression o...

Osborne, D.P.; Katz, D.H., 1977: The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction. The allogeneic effect has been employed as a potent immunopotentiator in preventing the growth of a murine plasmacytoma and prolonging host survival. Parental BALB/c spleen cells were passively transferred to (BALB/c x A/H)F1 hybrid mice, who were...

Fink D.W.Jr; Mirkin B.L., 1985: Effects of host age and 6 hydroxydopamine chemical sympathectomy on c 1300 murine neuroblastoma tumor growth in vivo. Federation Proceedings 44(5): 1385

Suzuki, E.; Kim, S.; Cheung, H-Kam.; Corbley, M.J.; Zhang, X.; Sun, L.; Shan, F.; Singh, J.; Lee, W-Cherng.; Albelda, S.M.; Ling, L.E., 2007: A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Malignant mesothelioma is an aggressive and lethal pleural cancer that overexpresses transforming growth factor beta (TGFbeta). We investigated the efficacy of a novel small-molecule TGFbeta type I receptor (ALK5) kinase inhibitor, SM16, in the AB...

Liu, F-Chang.; Pan, C-Hsu.; Lai, M-Tsung.; Chang, S-Jen.; Chung, J-Gung.; Wu, C-Hsi., 2013: Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model. The aim of this study was to explore the antitumor effect of Gan-Lu-Yin (GLY), a traditional Chinese herbal formula, on leukemia. Ethanolic extract of GLY was applied to evaluate its regulatory mechanisms in proliferation, migration, and different...

Kalaaji, A.N.; Lu, J.; Markovic, S.N.; Celis, E.; Pittelkow, M.R., 2010: Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model. Various cytokines, including interferon alpha (IFNalpha), tumor necrosis factor alpha (TNFalpha), and granulocyte-macrophage colony-stimulating factor (GM-CSF), have been used as adjuvant therapy for advanced-stage melanoma with some success but w...

Horn P.T.; Mirkin B.L., 1990: Modulation of in situ murine neuroblastoma tumor growth by the adrenergic nervous system differential response of clonal cell lines to chemical sympathectomy. The in situ growth characteristics of C-1300, N1E-115 and NS20Y murine neuroblastoma (MNB) tumor cell lines were compared in normal and sympathectomized A/J mice. Adrenergic nerve ablation was produced in neonatal mice by administration of 6-hydro...